Variation in Normal Range Thyroid Function Affects Serum Cholesterol Levels, Blood Pressure, and Type 2 Diabetes Risk: A Mendelian Randomization Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Observational studies have demonstrated that variation in normal range thyroid function is associated with major cardiovascular risk factors, including dyslipidemia, hypertension, type 2 diabetes (T2D), and obesity. As observational studies are prone to residual confounding, reverse causality, and selection bias, we used a Mendelian randomization (MR) approach to investigate whether these associations are causal or not. Methods: Two-sample MR analysis using data from the largest available genome-wide association studies on normal range thyrotropin (TSH) and free thyroxine (fT4) levels, serum lipid levels, blood pressure measurements, T2D, and obesity traits (body mass index [BMI] and waist/hip ratio). Results: A one standard deviation (SD) increase in genetically predicted TSH levels was associated with a 0.037 SD increase in total cholesterol levels ( p = 3.0 × 10 −4 ). After excluding pleiotropic instruments, we also observed significant associations between TSH levels and low-density lipoprotein levels (β = 0.026 SD, p = 1.9 × 10 −3 ), pulse pressure (β = −0.477 mmHg, p = 7.5 × 10 −10 ), and T2D risk (odds ratio = 0.95, p = 2.5 × 10 −3 ). While we found no evidence of causal associations between TSH or fT4 levels and obesity traits, we found that a one SD increase in genetically predicted BMI was associated with a 0.075 SD decrease in fT4 levels ( p = 3.6 × 10 −4 ). Conclusions: Variation in normal range thyroid function affects serum cholesterol levels, blood pressure, and T2D risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 7×
“…of horizontal pleiotropy when the pleiotropic effects of the genetic variants are independent from the genetic associations with the exposure (33), while WM can provide valid MR estimates under the presence of horizontal pleiotropy when up to half of the included instruments are invalid (34).”
InfluentialBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“First, we compared the results obtained using the IVW method with the results from MR Egger (33) and weighted median (WM) (34) methods, as the slope of the MR Egger regression may provide valid MR estimates in the presence of horizontal pleiotropy when the pleiotropic effects of the genetic…”
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404 · cited 2×
“The fundamental principle of MR is that if genetic variants alter the exposure that is causal for the outcome, then these genetic variants should also be associated with this outcome to the extent corresponding to their effects on the exposure (18,19).”
Avoiding bias from weak instruments in Mendelian randomization studies
Burgess, S., Thompson, S. G., & CRP CHD Genetics Collaboration (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr036 · Cited by 3,952
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S. F., Abyu, G., Ahmed, M., Aksut, B., Alam, T., Alam, K., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.052 · Cited by 3,791
Calculating statistical power in Mendelian randomization studies.
Brion, M.-J. A., Shakhbazov, K., & Visscher, P. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt179 · Cited by 1,751
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome
Greco M, F. D., Minelli, C., Sheehan, N. A., & Thompson, J. R. (2015) · Statistics in Medicine · doi:10.1002/sim.6522 · Cited by 1,700 · cited 1×
“Furthermore, we used I 2 statistics and Cochran’s Q test to quantify heterogeneity across the instruments, with p het 0.05 indicating the presence of significant heterogeneity suggesting pleiotropy (35).”
InfluentialBias and causal associations in observational research
Grimes, D. A., & Schulz, K. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07451-2 · Cited by 1,553
Program, T. M. V., Evangelou, E., Warren, H. R., Mosen-Ansorena, D., Mifsud, B., Pazoki, R., Gao, H., Ntritsos, G., Dimou, N., Cabrera, C. P., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0205-x · Cited by 1,381
Self-citationKnudsen, N., Laurberg, P., Rasmussen, L. B., Bülow, I., Perrild, H., Ovesen, L., & Jørgensen, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2225 · Cited by 753 · cited 1×
“Multiple observational studies showed that there is a positive association between BMI and TSH levels, even within the normal range (76).”
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729 · cited 1×
“There is evidence that thyroid disease is an important cause of secondary hypertension (48,49).”
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · cited 1×
“Furthermore, whereas over a lifetime, TSH and fT4 values oscillate around an individual set point (91), they also tend to change with age (32).”
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
Razvi, S., Ingoe, L., Keeka, G., Oates, C., McMillan, C., & Weaver, J. U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1869 · Cited by 389
Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*
SPENCER, C. A., LoPRESTI, J. S., PATEL, A., GUTTLER, R. B., EIGEN, A., SHEN, D., GRAY, D., & NICOLOFF, J. T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-453 · Cited by 371
Åsvold, B. O., Vatten, L. J., Nilsen, T. I. L., & Bjøro, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02333 · Cited by 350 · cited 1×
“Moreover, normal range TSH levels have been positively associated with total cholesterol, LDL-c, and TG levels, as well as negatively associated with HDL-c levels in various observational studies (11,40,41).”
Glymour, M. M., Tchetgen Tchetgen, E. J., & Robins, J. M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr323 · Cited by 292 · cited 2×
“This means that weak and pleiotropic instruments should be avoided as they can strongly bias the causal estimates (30,31).”
InfluentialPitfalls in the measurement and interpretation of thyroid function tests
Koulouri, O., Moran, C., Halsall, D., Chatterjee, K., & Gurnell, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.003 · Cited by 282
Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation
Teumer, A., Chaker, L., Groeneweg, S., Li, Y., Di Munno, C., Barbieri, C., Schultheiss, U. T., Traglia, M., Ahluwalia, T. S., Akiyama, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06356-1 · Cited by 280
Self-citationA Review of the Clinical Consequences of Variation in Thyroid Function Within the Reference Range
Taylor, P. N., Razvi, S., Pearce, S. H., & Dayan, C. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1315 · Cited by 274
Garduño-Garcia, J. D. J., Alvirde-Garcia, U., López-Carrasco, G., Padilla Mendoza, M. E., Mehta, R., Arellano-Campos, O., Choza, R., Sauque, L., Garay-Sevilla, M. E., Malacara, J. M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0312 · Cited by 268 · cited 1×
“Moreover, normal range TSH levels have been positively associated with total cholesterol, LDL-c, and TG levels, as well as negatively associated with HDL-c levels in various observational studies (11,40,41).”
Subclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis
Han, C., He, X., Xia, X., Li, Y., Shi, X., Shan, Z., & Teng, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135233 · Cited by 258 · cited 1×
“A meta-analysis of observational studies in Chinese has also reported an increased risk of diabetic complications in patients with coexisting T2D and subclinical hypothyroidism (65).”
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8302 · Cited by 245 · cited 1×
“Overt hyperthyroidism is accompanied by increased cardiac output and reduced vascular resistance resulting in increased SBP, decreased DBP, and increased pulse pressure (50).”
Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., & Vatten, L. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2208 · Cited by 215 · cited 5×
“Blood pressure TSH levels were not associated with SBP ( b = - 0.178 mmHg, p = 0.24) or DBP ( b = 0.160 mmHg, p = 0.080) in our primary analyses (Supplementary Table S4).”
InfluentialThyroid Function in the Euthyroid Range and Adverse Outcomes in Older Adults
Cappola, A. R., Arnold, A. M., Wulczyn, K., Carlson, M., Robbins, J., & Psaty, B. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3586 · Cited by 201
Moon, S., Kim, M. J., Yu, J. M., Yoo, H. J., & Park, Y. J. (2018) · Thyroid · doi:10.1089/thy.2017.0414 · Cited by 175
Fommei, E., & Iervasi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.1996 · Cited by 172
Defending plasma T3 is a biological priority
Abdalla, S. M., & Bianco, A. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12538 · Cited by 147
Hypothyroidism as a cause of hypertension.
Saito, I., Ito, K., & Saruta, T. (1983) · Hypertension · doi:10.1161/01.hyp.5.1.112 · Cited by 135 · cited 5×
“Blood pressure TSH levels were not associated with SBP ( b = - 0.178 mmHg, p = 0.24) or DBP ( b = 0.160 mmHg, p = 0.080) in our primary analyses (Supplementary Table S4).”
InfluentialThyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., Gunnell, D., & Vatten, L. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.855 · Cited by 125
MECHANISMS IN ENDOCRINOLOGY: Beyond the fixed setpoint of the hypothalamus–pituitary–thyroid axis
Fliers, E., Kalsbeek, A., & Boelen, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0285 · Cited by 124
Increased central arterial stiffness in hypothyroidism
Obuobie, K., Smith, J., Evans, L. M., John, R., Davies, J. S., & Lazarus, J. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020493 · Cited by 119
Thyroid function characteristics and determinants: the Rotterdam study.
Chaker, L., Korevaar, T. I. M., Medici, M., Uitterlinden, A. G., Hofman, A., Dehghan, A., Franco, O. H., & Peeters, R. P. (2016) · Thyroid · doi:10.1089/thy.2016.0133 · Cited by 118
Self-citationChaker, L., Baumgartner, C., den Elzen, W. P. J., Collet, T.-H., Ikram, M. A., Blum, M. R., Dehghan, A., Drechsler, C., Luben, R. N., Portegies, M. L. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2255 · Cited by 92
Self-citationOrtega, F. J., Jílková, Z. M., Moreno-Navarrete, J. M., Pavelka, S., Rodriguez-Hermosa, J. I., Kopeckỳ, J., & Fernández-Real, J. M. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.101 · Cited by 80 · cited 1×
“…of type 1 deiodinase (DIO1) and type 2 deiodinase (DIO2) in the white adipose tissue (WAT), in comparison with DIO1 expression in the liver or DIO2 expression in the brown adipose tissue (BAT), is minimal (82,83), it has been shown that the DIO1 activity in WAT is increased in obese subjects (84).”
Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study
Marouli, E., Kus, A., Del Greco M, F., Chaker, L., Peeters, R., Teumer, A., Deloukas, P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa239 · Cited by 57
Self-citationRothacker, K. M., Brown, S. J., Hadlow, N. C., Wardrop, R., & Walsh, J. P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4011 · Cited by 51
Taylor, P. N., Richmond, R., Davies, N., Sayers, A., Stevenson, K., Woltersdorf, W., Taylor, A., Groom, A., Northstone, K., Ring, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3505 · Cited by 48 · cited 1×
“An MR study performed by Taylor et al. found that higher BMI leads to higher fT3 levels in children, while no effect of genetically predicted BMI on fT4 levels was observed in that study (81).”
The Genetic Basis of Thyroid Function: Novel Findings and New Approaches
Kuś, A., Chaker, L., Teumer, A., Peeters, R. P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz225 · Cited by 44 · cited 1×
“…within genes encoding transcription factors implicated in the pituitary and thyroid development ( FOXE1 , LHX3 ), TH transporters ( SLCO1B1 , SLC17A4 ), TH metabolizing enzymes ( DIO1 , DIO2 , AADAT ), and multiple loci without a known function in the hypothalamus/pituitary/thyroid axis (95).”
Self-citationBoelen, A., van Beeren, M., Vos, X., Surovtseva, O., Belegri, E., Saaltink, D.-J., Vreugdenhil, E., Kalsbeek, A., Kwakkel, J., & Fliers, E. (2012) · Thyroid · doi:10.1089/thy.2011.0289 · Cited by 35
He, W., Li, S., Wang, B., Mu, K., Shao, X., Yao, Q., Li, L., Li, Q., & Zhang, J.-A. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000001826 · Cited by 21
The importance of high-quality mendelian randomisation studies for clinical thyroidology
Medici, M., Peeters, R. P., Teumer, A., & Taylor, P. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30145-7 · Cited by 14 · cited 1×
“Consequently, while these variants can be used as instruments reflecting variation in normal range fT4 levels, they should not be interpreted as being instruments for increased thyroid function (96).”
Self-citation
Cited by
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Self-citationSterenborg, R. B. T. M., Steinbrenner, I., Li, Y., Bujnis, M. N., Naito, T., Marouli, E., Galesloot, T. E., Babajide, O., Andreasen, L., Astrup, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44701-9 · Cited by 79
The ageing thyroid: implications for longevity and patient care
van Heemst, D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00911-7 · Cited by 43
A Deeper Understanding of the Causal Relationships Between Thyroid Function and Atrial Fibrillation
Kuś, A., Teumer, A., & Medici, M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab525 · Cited by 4
Self-citation
Metadata
- Authors
- Kuś, A., Marouli, E., Del Greco M., F., Chaker, L., Bednarczuk, T., Peeters, R. P., Teumer, A., Medici, M., & Deloukas, P.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2021-05-01
- Volume
- 31
- Issue
- 5
- Pages
- 721-731
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W3047258517
- Cited by
- 51
- References
- 44
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.